Meds & supplements › Ledipasvir
Medicine · Hepatitis C Virus NS5A Inhibitor
Ledipasvir and sofosbuvir is indicated for the treatment of adults and pediatric patients 3 years of age and older with chronic hepatitis C virus (HCV): genotype 1, 4, 5
Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗
Ledipasvir and sofosbuvir is indicated for the treatment of adults and pediatric patients 3 years of age and older with chronic hepatitis C virus (HCV):
The following serious adverse reactions are described below and elsewhere in labeling:
If ledipasvir and sofosbuvir is administered with ribavirin, the contraindications to ribavirin also apply to this combination regimen. Refer to the ribavirin prescribing information for a list of contraindications for ribavirin.
Store at room temperature below 30 °C (86 °F).
sofidex [Internet]. Daloreum; c2026. Ledipasvir; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/ledipasvir
sofidex. (2026, August 3). Ledipasvir. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/ledipasvir
Ledipasvir. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/ledipasvir
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.